Abstract:  Surgical approaches for adenocarcinoma of esophagogastric junction have become controversial issues in recent years, including complete resection of tumors, negative proximal margin, complete lymph node dissection, safety of digestive tract reconstruction and reduction of perioperative com-plications. JCOG9502 trial in Japan is a well-known clinical trial on the surgical approach for adenocarcinoma of esophagogastric junction, which provides evidence-based medicine results for the transabdominal or transthoracic approach. However, due to the differences between the left and right thoracic approaches, the choice of a reasonable surgical approach has also become the focus of discussion between eastern and western scholars. With the development of minimally invasive surgery, it is possible to perform the operations combining laparoscopy and thoracoscopy in the future.